Stay updated on Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial

Sign up to get notified when there's something new on the Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The record history now shows a new revision (v3.5.5) replacing the prior v3.5.4. This indicates an updated version of the study record in ClinicalTrials.gov history.
    Difference
    0.1%
    Check dated 2026-06-05T10:18:56.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    A new Results Submission Events (1) entry appears in the Record History, and the revision is updated from v3.5.3 to v3.5.4 to reflect the latest version of the study record.
    Difference
    0.3%
    Check dated 2026-05-15T02:16:34.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    A new revision entry v3.5.3 was added to the Record History, replacing the previous v3.5.2 entry in the revision timeline.
    Difference
    0.1%
    Check dated 2026-04-30T17:55:16.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Updated the study record history to reflect that **results were submitted** (replacing the prior state of **no results posted**), signaling the availability pipeline for trial outcomes.
    Difference
    0.1%
    Check dated 2026-04-23T14:57:05.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Revision: v3.5.2 added and Revision: v3.5.0 removed in the Study Record History.
    Difference
    0.1%
    Check dated 2026-04-16T10:49:10.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Revision v3.5.0 was added and revision v3.4.3 was removed from the study's history.
    Difference
    0.1%
    Check dated 2026-03-18T16:48:51.000Z thumbnail image

Stay in the know with updates to Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial page.